SG Stock MarketDetailed Quotes

HQXW IX BiopharmaW260718

Watchlist
  • 0.004
  • 0.0000.00%
10min DelayMarket Closed Sep 18 09:18 CST
3.53MMarket Cap0.00P/E (TTM)

IX BiopharmaW260718 Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(Q2)Dec 31, 2019
(Q1)Sep 30, 2019
Total revenue
-58.91%5.91M
724.64%14.39M
77.16%1.75M
985K
174K
120K
Cost of revenue
71.10%3.59M
-1.27%2.1M
35.31%2.13M
1.57M
334K
355K
Gross profit
-81.12%2.32M
3,317.28%12.29M
34.92%-382K
-587K
-160K
-235K
Operating expense
-2.60%10.73M
14.19%11.02M
-7.39%9.65M
10.42M
2.58M
2.5M
Selling and administrative expenses
-4.37%9.04M
13.94%9.46M
-3.54%8.3M
--8.61M
--2.28M
--2.01M
-Selling and marketing expense
52.96%3.17M
-7.74%2.08M
-0.44%2.25M
--2.26M
--543K
--648K
-General and administrative expense
-20.48%5.87M
22.00%7.38M
-4.65%6.05M
--6.35M
--1.73M
--1.36M
Research and development costs
20.93%2.82M
-15.11%2.33M
9.92%2.75M
--2.5M
--522K
--715K
Total other operating income
46.76%1.13M
-44.82%772K
103.94%1.4M
--686K
--219K
--219K
Operating profit
-760.72%-8.41M
112.69%1.27M
8.86%-10.03M
-11.01M
-2.74M
-2.74M
Net non-operating interest income expense
-30.69%-264K
-20.96%-202K
-10.60%-167K
-151K
-57K
-62K
Non-operating interest income
--7K
--0
-91.95%7K
--87K
----
----
Non-operating interest expense
34.16%271K
16.09%202K
-26.89%174K
--238K
--57K
--62K
Net investment income
-45.11%-2.77M
-206.46%-1.91M
367.45%1.8M
384K
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets
153.45%1.74M
-3.26M
0
Income from associates and other participating interests
Special income /charges
Other non-operating income /expenses
-38.10%169K
273K
376K
-544K
Income before tax
-136.79%-9.71M
50.21%-4.1M
21.58%-8.23M
-10.5M
-2.42M
-3.35M
Income tax
-118.24%-91K
49,800.00%499K
1K
0
0
0
Net income
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-10.5M
-2.42M
-3.35M
Net income continuous operations
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
---10.5M
---2.42M
---3.35M
Net income discontinuous operations
----
----
----
----
--0
--0
Noncontrolling interests
Net income attributable to the company
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-10.5M
-2.42M
-3.35M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
Net income attributable to common stockholders
-109.11%-9.62M
44.16%-4.6M
21.57%-8.23M
-10.5M
-2.42M
-3.35M
Gross dividend payment
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(Q2)Dec 31, 2019(Q1)Sep 30, 2019
Total revenue -58.91%5.91M724.64%14.39M77.16%1.75M985K174K120K
Cost of revenue 71.10%3.59M-1.27%2.1M35.31%2.13M1.57M334K355K
Gross profit -81.12%2.32M3,317.28%12.29M34.92%-382K-587K-160K-235K
Operating expense -2.60%10.73M14.19%11.02M-7.39%9.65M10.42M2.58M2.5M
Selling and administrative expenses -4.37%9.04M13.94%9.46M-3.54%8.3M--8.61M--2.28M--2.01M
-Selling and marketing expense 52.96%3.17M-7.74%2.08M-0.44%2.25M--2.26M--543K--648K
-General and administrative expense -20.48%5.87M22.00%7.38M-4.65%6.05M--6.35M--1.73M--1.36M
Research and development costs 20.93%2.82M-15.11%2.33M9.92%2.75M--2.5M--522K--715K
Total other operating income 46.76%1.13M-44.82%772K103.94%1.4M--686K--219K--219K
Operating profit -760.72%-8.41M112.69%1.27M8.86%-10.03M-11.01M-2.74M-2.74M
Net non-operating interest income expense -30.69%-264K-20.96%-202K-10.60%-167K-151K-57K-62K
Non-operating interest income --7K--0-91.95%7K--87K--------
Non-operating interest expense 34.16%271K16.09%202K-26.89%174K--238K--57K--62K
Net investment income -45.11%-2.77M-206.46%-1.91M367.45%1.8M384K
Gain/Loss on financial instruments designated as cash flow hedges
Gain/Loss on derecognition of available-for-sale financial assets 153.45%1.74M-3.26M0
Income from associates and other participating interests
Special income /charges
Other non-operating income /expenses -38.10%169K273K376K-544K
Income before tax -136.79%-9.71M50.21%-4.1M21.58%-8.23M-10.5M-2.42M-3.35M
Income tax -118.24%-91K49,800.00%499K1K000
Net income -109.11%-9.62M44.16%-4.6M21.57%-8.23M-10.5M-2.42M-3.35M
Net income continuous operations -109.11%-9.62M44.16%-4.6M21.57%-8.23M---10.5M---2.42M---3.35M
Net income discontinuous operations ------------------0--0
Noncontrolling interests
Net income attributable to the company -109.11%-9.62M44.16%-4.6M21.57%-8.23M-10.5M-2.42M-3.35M
Preferred stock dividends
Other under preferred stock dividend 000000
Net income attributable to common stockholders -109.11%-9.62M44.16%-4.6M21.57%-8.23M-10.5M-2.42M-3.35M
Gross dividend payment
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit SGDSGDSGDSGDSGDSGD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
SG
Overall
Symbol
Latest Price
% Chg

No Data